2014 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

News

 

Advanced Vascular Dynamics’ TibioPedal Hemostasis Device Cleared in US and Europe

December 18, 2014 -- Advanced Vascular Dynamics announced US Food and Drug Administration clearance and European CE Mark approval of the company’s Radar vascular compres…

Societies Respond to Publication of MR CLEAN Trial Data

December 17, 2014 -- The Society of Neurointerventional Surgery (SNIS) and the European Society of Minimally Invasive Neurological Therapy (ESMINT) have commented on the publi…

FDA Clears ReFlow Medical’s Spex Shapeable Support Catheter

December 17, 2014 -- ReFlow Medical, Inc. announced US Food and Drug Administration clearance for commercialization of the company’s Spex shapeable support catheter for …

Philips to Acquire Volcano

December 17, 2014 -- Royal Philips and Volcano Corporation announced that they have entered into a definitive merger agreement. Pursuant to the agreement, Philips will commenc…

Published MR CLEAN Trial Data Show Benefit of Intra-arterial Treatment for Acute Ischemic Stroke

December 17, 2014 -- MR CLEAN, a randomized trial of intra-arterial treatment for acute ischemic stroke, was published by Olvert A. Berkhemer, MD, et al online ahead of print …

Infraredx Highlights Study Supporting Predictive Value of Near-Infrared Spectroscopy

December 9, 2014 -- Infraredx, Inc. announced results from an independent, prospective outcomes study published that evaluated the ability of intravascular near-infrared …

Initial Results Published for Spectranetics’ EXCITE ISR Trial

December 10, 2014 -- Initial results from the EXCITE ISR (Excimer Laser Randomized Controlled Study for Treatment of Femoropopliteal In-Stent Restenosis) trial were publi…

Click here for more News coverage

Current Supplement

United States

Sponsored by COOK MEDICAL

The Rise of Peripheral Drug Elution

How to incorporate drug-coated balloons and drug-eluting stents into your practice.

Europe

Sponsored by COOK MEDICAL

The Next Chapter in TEVAR

Moving Technology Toward Patient Needs

Invention and Intellectual Property

Protecting Your Inventions, From Idea to Marketplace

The first step in bringing your medical device to market is to understand who owns the rights to your invention.

Beginning the Patent Process

The second step in bringing your medical device to market is to understand whether you can protect your invention.

Evaluating Freedom to Operate

The third step in bringing your medical device to market is to understand whether you can practice your invention.

Featured Center

 

Embolization

advertisement

 
Vascular Market Price  Change
Abbott Laboratories $45.96  0.42%
AstraZeneca PLC $71.00  -1.54%
Boston Scientific Corporation $13.27  0.04%
BTG plc $805.50  0.00%
Cardiovascular Systems Inc. $30.34  -1.04%
Covidien plc $102.96  -0.25%
CR Bard Inc. $172.15  0.33%
Edwards Lifesciences Corp. $131.97  0.43%
Endologix Inc. $14.66  0.34%
Hansen Medical, Inc. $0.63  7.44%
Vascular Market Price  Change
Johnson and Johnson $106.03  -0.73%
Lombard Medical, Inc. $5.48  3.43%
Medtronic, Inc. $74.28  -0.47%
Merit Medical Systems, Inc. $16.84  -1.12%
St. Jude Medical Inc. $67.11  -0.19%
The Medicines Company $26.99  -0.18%
The Spectranetics Corporation $34.33  -2.33%
TriVascular Technologies, Inc. $12.86  -0.39%
Vascular Solutions Inc. $27.21  -1.31%
Volcano Corporation $10.30  1.78%

@EVToday

Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.

Website Design by Sides Media